{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "LAKE FOREST",
      "state": "IL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {
        "application_number": [
          "ANDA070172"
        ],
        "brand_name": [
          "NALOXONE HYDROCHLORIDE"
        ],
        "generic_name": [
          "NALOXONE HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Hospira, Inc."
        ],
        "product_ndc": [
          "0409-1782"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAMUSCULAR",
          "INTRAVENOUS",
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "NALOXONE HYDROCHLORIDE"
        ],
        "rxcui": [
          "1191234"
        ],
        "spl_id": [
          "568bacb5-8e96-46d9-8717-23951594a9fb"
        ],
        "spl_set_id": [
          "b598c237-032d-4bb5-0e92-50eabd863dac"
        ],
        "package_ndc": [
          "0409-1782-03",
          "0409-1782-69"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "F850569PQR"
        ]
      },
      "product_type": "Drugs",
      "event_id": "80167",
      "recalling_firm": "HOSPIRA INC, LAKE FOREST",
      "address_1": "275 NORTH FOREST DRIVE",
      "address_2": "N/A",
      "postal_code": "60045",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide in the U.S., Puerto Rico, and Guam",
      "recall_number": "D-0906-2018",
      "product_description": "Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and 10 count box (NDC 0409-1782-69), Rx Only, Hospira Inc., Lake Forest, IL",
      "product_quantity": "164,860 syringes",
      "reason_for_recall": "Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.",
      "recall_initiation_date": "20180604",
      "center_classification_date": "20180702",
      "termination_date": "20200327",
      "report_date": "20180613",
      "code_info": "72680LL, Exp. 1DEC2018 (NDC 0409-1782-03); 76510LL, Exp. 1APR2019 (NDC 0409-1782-69)"
    }
  ]
}